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1. Introduction
   Growth arrest and DNA damage-inducible protein 34 
(GADD34) is a kind of cell cycle protein that can be up-
regulated under conditions of DNA damage, cell cycle 
arrest and endoplasmic reticulum (ER) dysfunction, etc[1]. 
Some animal models with cerebral ischemia indicated 
that GADD34 expression was up-regulated at certain 
time windows after cerebral ischemia, but there was 
no consistent conclusion on the dynamic changes of 
GADD34 expression due to the different animal breeds 
and models used in the researches[2,3]. Edaravone can 
scavenge free radicals and is verified to have neuro-
protection function in animal experiments. However, its 
influence on GADD34 expression has been rarely reported 
in recent years. In this study, edaravone was used as 
an interventional agent to detect the GADD34 expression 
changes in peri-infarct regions on ischemic parietal 
cortex, hoping to provide experimental basis for the 
prevention and treatment of cerebral infarction. 
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Objective: To investigate the influence of edaravone on the expression of growth arrest and DNA 
damage-inducible protein 34 (GADD34). 
Methods: A total of 108 healthy male Sprague-Dawley rats were randomly divided into sham 
operation group, model group and edaravone group (36 cases for each group). Transient focal 
cerebral ischemia was induced by middle cerebral artery occlusion for 2 h followed by reperfusion 
in Sprague-Dawley rats. Then, GADD34 expression was measured with immunohistochemistry at 
different time-points after reperfusion in the peri-infarct regions of all rats. 
Results: The GADD34 expression was detected in the peri-infarct regions of rats 1 h after 
reperfusion, which reached its peak 24 h after reperfusion. And edaravone could significantly 
down-regulate the GADD34 expression. 
Conclusions: Edaravon could down-regulate GADD34 expression, which suggests that edaravone 
may exert an important function in inhibiting endoplasmic reticulum stress reaction by 
scavenging free radicals in the upper stream.
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Comments
This work explores the effect of the 
new agent, edaravone on GADD34 
expression following focal cerebral 
ischemia-reperfusion in rats. The 
animal model is new and shows new 
finding that can be useful for further 
referencing in antioxidant research.
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2. Materials and methods 
2.1. Materials 
   Edaravone was supplied by Jiangsu Simcere Company, 
GADD34 antibody was purchased from American Santa 
Cruz Company, and streptavidin-biotin complex (SABC) 
immunohistochemical kits and diaminobenzidine stain were 
brought from Wuhan Boster Biological Technology, Ltd. 
2.2. Animal models and grouping
   A total of 108 healthy male Sprague-Dawley (SD) rats (230-
280 g) aged 10-12 weeks were fed by full-price nutritional 
fodders at 18-25 °C room temperature, 50%-60% relative 
humidity and 12 h diurnal cycle of illumination. All rats 
could eat and drink freely. Then they were randomly 
divided into sham operation group, model group and 
edaravone group by random number table (36 cases for each 
group). Suture-occluded method reported by Paschen et 
al. was adopted to prepare left focal middle cerebral artery 
(MCA) occlusion models[4]. The occlusion was maintained 
for 120 min and then unplugged to form reperfusion. After 
model rats revived, neurological deficit score was conducted 
based on the level V of Paschen’s standard scoring 
method[4]. Rats with 1-3 scores in the initial neurological 
deficit score were included, whereas the dead rats, or whose 
with subarachnoid hemorrhage and without contralateral 
hemiplegia signs were considered as failed ones. Successful 
rat models in the same period were selected to supplement 
the object numbers. And then, the two groups were divided 
into six subgroups according to the reperfusion times such 
as reperfusion 1, 3, 6, 12, 24 and 72 h groups (12 cases for 
each group). At each perfusion corresponding time, the rats 
were sacrificed. 
2.3. Methods 
2.3.1. Edaravone group
   A volume of 10 mg edaravone injection (Trade name: 
Edaravone; Batch number: H20031342; Specification: 10 mg/5 
mL) was diluted by 5 mL normal saline to prepare 1 mg/mL 
solution. About 3 mg/kg edaravone injection was injected 
into the caudal veins immediately after reperfusion. 
2.3.2. Model group 
   A total of 3 mL/kg normal saline was injected into the 
caudal veins immediately after reperfusion. 
2.3.3. Sham operation group 
   This group was divided into six subgroups according to the 
above reperfusion corresponding times (six cases for each). 
In this group, suture occlusions were inserted 8-10 mm in 
depth so as to maintain the smooth of anterior and posterior 
MCA. The rest operations were similar to those in other 
groups. 
2.4. Preparation of paraffin sections 
   At reperfusion corresponding time-point, 10% chloral 
hydrate was used to narcotize the rats, and then 250 mL 
0.9% normal saline was infused from apex cordis. When 
the solution discharged from the right atrial appendage 
was clear, 300 mL 4% paraformaldehyde was infused. All 
rat brains were decollated and the part from antinion to 
occipital lobe was divided into five equal sections marked 
as A, B, C, D and E. C section was embedded by paraffin to 
prepare the consistent slices (4 µm in thickness). 
2.5. Immunohistochemical staining 
   SABC was used. The potency of GADD34 polyclonal 
antibodies was verified to be 1:100 by the pre-experiment, 
and the detailed operations were as follows. The slices were 
routinely deparaffinaged into water, soaked in 3% H2O2 
at room temperature for 5-10 min, and washed by double 
distilled water by 2 min伊3 times. The antigen was repaired 
by microwave heating, washed by 0.1 mol/L phosphate buffer 
solution (PBS) by 2 min伊2 times after natural refrigeration; 
added with normal goat serum blocking buffer, incubated at 
room temperature for 20 min and the serum was discarded; 
then added with the primary antibodies of rabbit anti-
mice GADD34 polyclonal antibodies (1:100), incubated at 4 °C 
overnight, washed by 0.1 mol/L PBS by 2 min伊3 times; added 
with biotinylated goat anti-rabbit IgG antibodies (carried 
with kits with potency 1:100), incubated at 37 °C for 20 min 
and washed by 0.1 mol/L PBS by 2 min伊3 times; added with 
SABC, incubated at 37 °C for 30 min and washed by 0.1 mol/
L PBS by 5 min伊4 times; added with diaminobenzidine to 
develop color; and then dehydrated, transparentized and 
sealed. The above steps were performed in sequence. Five 
fields were randomly collected in the peri-infarct regions 
of ischemic cortex of each rat under microscope (伊400), and 
the mean value was regarded as the estimated value. High-
definition pathological image analysis system (HPIAS-1000) 
was applied to analyze the images of slices and determine 
the grey value of positive protein expression. 
2.6. Statistical data analysis
   SPSS 11.5 software was applied for all data analysis. All 
data were expressed as mean依SD. One-way ANOVA was 
used for the comparisons of multi-sample means while 
student’s t-test was for comparisons among groups with 
α=0.05. P<0.05 was considered to be statistically significant. 
3. Results 
   In sham operation group, there were positive GADD34 
immunoreactive cell expressions in the left side of the 
parietal cortex, but ANOVA test showed no significant 
differences in GADD34 immunoreactive cell expressions 
at each time point (P>0.05). In model group, 1 h after 
reperfusion, GADD34 expression increased in peri-
infarct regions on ischemic parietal cortex, whose grey 
values decreased along with the prolonged reperfusion 
times, indicating that the counts of positive GADD34 cells 
increased gradually and reached its peak at 24 h, and even 
72 h after reperfusion, the positive cells were still visible. 
However, the GADD34 expression, marked by dynamic 
changes, were evidently higher in edaravone group 6, 12 
and 24 h after reperfusion than in model group (P<0.05), but 
the differences at other time-points were not statistically 
significant (P>0.05), as shown in Table 1 and Figures 1 and 
2. 
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Figure 1. GADD34 positive cell expression in peri-infarct regions of left 
parietal cortex 24 h after reperfusion in model group.
Fgure 2. GADD34 positive cell expression in peri-infarct regions of left 
parietal cortex 24 h after reperfusion in edaravone group.
4. Discussion
   GADD34 is a kind of cell cycle protein that can be up-
regulated under conditions of DNA damage, cell cycle 
arrest and ER dysfunction, etc[4]. A recent study on GADD34 
genes in fibroblasts in rats proved that this protein could 
dephosphorylate eIF2α and repair endoplasmic reticulum stress 
(ERS) associated protein synthesis inhibition[5,6]. Therefore, it 
can be said that GADD34 gene expression is limited by ERS, 
becoming a critical factor for the successful recovery of protein 
synthesis function. 
   According to the known functions of GADD34, it can be 
concluded that the increased protein compound expressions 
of GADD34 serve the purposes of alleviating ischemia induced 
protein synthesis inhibition, repairing damaged DNA and 
influencing programmed cell death (apoptosis)[7-10]. However, 
the intriguing point is that the pre-treatment of ischemia could 
obviously reduce the cerebral ischemia-reperfusion induced 
protein synthesis inhibition[11]. Garcia et al. reported that 
GADD34 was one of the proteins induced by the pre-stimulation 
of ischemia (5 min sub-fatal stimulation) and could be strongly 
translated during reperfusion after fatal ischemia, for which the 
pre-treatment of ischemia could remarkably protect the brains 
so as to response to the fatal ischemic stimulation for 30 min[11]. 
   The existing animal experiments proved that cerebral 
ischemia could induce ERS and improve unfolded protein 
response. However, the dynamic changes were not consistent 
due to the different animal breeds and models used in 
researches. Hu et al. made male SD rat models with focal 
cerebral ischemia by electrocoagulation to observe the GADD34 
expression changes at different time points after ischemia[12], 
and the results revealed that 4 h after operation, the ischemic 
brains were detected with GADD34 immune positive cells 
(mainly neurons). The cells were the most intensive in peri-
infarct regions, and there was significant difference when 
compared with those in contralateral cerebral cortex. And 24 h 
after operation, the immune positive cell expressions reached 
the peak, and the double staining of GADD34 and terminal 
deoxynucleotidyl transferase mediated nick end labeling 
immunofluorescence showed deficient co-localization of 
neurons in the ischemic cortex. In this study, it was found that 
GADD34 expression, which was up-regulated at certain time 
after cerebral ischemia-reperfusion, could be detected 1 h 
after reperfusion and reached to the peak 24 h after reperfusion, 
which further proved that reperfusion could induce ERS and 
improve unfolded protein response target gene expression. 
   Edaravone (3-methyl-1-phenyl-2-pyrazon-5-ketone), as a 
new colorless transparent free radical scavenger, can effectively 
scavenge hydroxyl free radicals by inhibiting activities of 
hydroxyl free radicals, lipid peroxidation and ferric ion 
induced peroxidation injury. Additionally, it can also inhibit 
the activities of xanthine oxidase and hypoxanthine oxidase, 
improve the activity of superoxide dismutase, strengthen the 
total anti-oxidation function of cells, inhibit the peroxidation 
of cell membranes as well as stimulate the formation of 
prostaglandin, reduce the level of inflammatory factor 
leukotriene so as to significantly promote the cell stability, 
protect neurocytes, decrease cell apoptosis and increase cell 
survival rates. Previous study showed that edaravone had 
neuroprotective effect in that it could down-regulate the ERS 
gene expressions after cerebral ischemia-reperfusion, such as 
PKR-like endoplasmic reticulum kinase and C/EBP homology 
protein, and reduce the apoptosis of nerve cells in peri-infarct 
regions[13-15]. Other clinical trials also demonstrated that the 
mechanism of neuroprotective effect of edaravone was that it 
could alleviate the damage of vascular endothelial cell, inhibit 
the delayed neuron necrosis and apparently reduce the cerebral 
infarction volume injured by the obstruction-reperfusion of 
unilateral MCA[16-19] . 
   This study found that edaravone could reduce GADD34 
expression in SD rat models with cerebral ischemia-
reperfusion, while GADD34 was verified to be effective in 
protecting nerves and beneficial to cell survivals. Therefore, it 
is controversial that whether the cerebral ischemia-reperfusion 
may be aggravated if GADD34 expression is inhibited by 
Table 1 
Comparison of mean gray values of GADD34 expression on left parietal cortex (mean依SD).
Groups Mean gray values of GADD34 
1 h 3 h 6 h 12 h 24 h 72 h
Sham operation group      167.77依8.55      166.39依8.08    166.54依7.74     164.62依7.40     167.06依8.11      168.61依9.35
Model group 151.72依9.92** 147.68依8.79**    125.72依7.66**     121.99依6.73**     105.99依7.02**  158.76依10.28**
Edaravone group 155.91依9.35** 152.05依11.7** 140.23依11.51**## 138.22依8.59**## 121.65依8.37**## 161.76依8.69**
**P<0.01 compared with sham operation group; ##P<0.01 compared with model group. 
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edaravone. The cell outcome mainly depends on the strength 
and duration of ERS because ERS has both increased expression 
of apoptosis-promoting molecule C/EBP homology protein and 
up-regulated expressions of pro-survival molecules GADD34 
and GRP78, which means that the relationship between GADD34 
expression and ERS is the power comparison of survival and 
death. So it was predicated that, through scavenging free 
radicals, edaravone could evidently relieve oxidative stress in 
ischemic penumbra and protect ER against lipid peroxidation 
so as to inhibit the ERS and ERS gene expression in upper stream 
and play its neuroprotective effect. 
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Comments 
Background
   This is a basic laboratory study on influence of edaravone 
on GADD34 expression following focal cerebral ischemia-
reperfusion in rats. It is a good experimental study in animal 
model.
  
Research frontiers
   The work explores a new aspect on effect of the new chemical 
edaravone on GADD34 expression following focal cerebral 
ischemia-reperfusion in animal model. It is a new finding in 
antioxidant research.
 
Related reports
   There is no previous report using this model for exploration on 
the effect of edaravone.
Innovations and breakthroughs
   This is an actual innovation in antioxidant research. It is also 
a new report on the new agent, edaravone. The study on GADD34 
expression following focal cerebral ischemia-reperfusion in rats 
is a new model study.
  
Applications
   It can be further applied in the field of antioxidant research. 
The work can be further referenced in the field of pharmacology 
as well.    
Peer review
   This work explores the effect of the new agent, edaravone 
on GADD34 expression following focal cerebral ischemia-
reperfusion in rats. The animal model is new and shows new 
finding that can be useful for further referencing in antioxidant 
research.
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